secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001213900-24-089013
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma auditor WWC P.C. declines renewal; Simon & Edward LLP appointed
------------------------------------------------------------------------------

- WWC agreed not to renew engagement effective Oct 10, 2024; Board approved non-renewal on Oct 17.
- Board approved engagement of Simon & Edward, LLP as new independent registered public accounting firm on Oct 17.
- WWC's reports for FY2022-2023 and interim Jun 2024 had no adverse opinion except a going concern paragraph.
- No disagreements or reportable events between Company and WWC during the relevant periods.
- Prior consultations with S&E regarding accounting principles or disagreements did not occur.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024089013/0001213900-24-089013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390024089013/ea0218060-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-089013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer